This is a Phase Ib/II, open-label, multicenter, randomized, umbrella study in patients with locally advanced SCCHN. The study will enroll treatment-naive patients with resectable Stage III-IVA HPV-negative, PD-L1 positive SCCHN with measurable disease.
COM_RESEARCHSTUDIES_DETAIL_HEADER_BASIC_CONTACT_4
North Carolina (Statewide)
Shetal Patel
Lineberger Comprehensive Cancer Center
Clinical or Medical
Interventional
Cancer (Head and Neck)
22-2886